Role of Oxidative Stress in Endothelial Dysfunction and Enhanced Responses to Angiotensin II of Afferent Arterioles from Rabbits Infused with Angiotensin II

Journal of the American Society of Nephrology

Volumn 14, Issue 11, 2003, Pages 2783-2789

  Wang, Dan ^a   Chen, Yifan ^a   Chabrashvili, Tina ^a   Aslam, Shakil ^a   Borrego Conde, Lillian J ^a   Umans, Jason G ^a   Wilcox, Christopher S ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE; NORADRENALIN; OXYGEN; PROTEIN; PROTEIN P22 PHOX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; TEMPOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; HYPERTENSION; KIDNEY CORTEX; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; VASOCONSTRICTION; VASODILATATION;

EID: 0142151745     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000090747.59919.D2     Document Type: Article

References (34)

1. Kawada N, Imai E, Karber A, Welch WJ, Wilcox CS: A mouse model of angiotensin II slow pressor response: Role of oxidative stress. J Am Soc Nephrol 13: 2860-2868, 2002
2. Lever AF: The fast and slow developing pressor effect of angiotensin II. In: The Renin-Angiotensin System, edited by Robertson JIS, Nicholls MG, London UK, Gower Medical Publishing, 1993, pp 28.1-28.9
3. Dickinson CJ, Yu R: Mechanisms involved in the progressive pressor response to very small amounts of angiotensin II in conscious rabbits. Circ Res XX and XI[Suppl II]: II-157-II-163, 1967
4. Ames RP, Borkowski AJ, Sicinski AM, Laragh JH: Prolonged infusions of angiotensin II and norepinephrine and blood pressure, electrolyte balance, aldosterone and cortisol secretion in normal man and in cirrhosis with ascites. J Clin Invest 44: 1171-1186, 1965
5. Brown AJ, Casals-Stenzel J, Gofford S, Lever AF, Morton JJ: Comparison of fast and slow pressor effects of angiotensin II in the conscious rats. Am J Physiol 241: H381-H388, 1981
6. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG: Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95: 588-593, 1997
7. Imig JD: Afferent arteriolar reactivity to angiotensin II is enhanced during the early phase of angiotensin II hypertension. Am J Hypertens 13: 810-818, 2000
8. Ortiz MC, Manriquez MC, Romero JC, Juncos LA: Antioxidants block angiotensin II-induced increases in blood pressure and endothelin. Hypertension 38: 655-659, 2001
9. Haas JA, Krier JD, Bolterman RJ, Juncos LA, Romero JC: Low-dose angiotensin II increases free isoprostane levels in plasma. Hypertension 34: 983-986, 1999
10. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG: Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923, 1996
11. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW: Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 1.141-1148, 1994
12. Pagano PJ, Clark JK, Cifuentes-Pagano ME, Clark SM, Callis GM, Quinn MT: Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: Enhancement by angiotensin II. Proc Natl Acad Sci U S A 94: 14483-14488, 1997
13. Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers IQ, Taylor WR, Harrison DG, Leon H, Wilcox JN, Griendling KK: P22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 80: 45-51, 1998
14. phox homologues in vascular smooth muscle cells nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88: 888-894, 2001
15. Chabrashvili T, Kitiyakara C, Blau J, Karber A, Aslam S, Welch WJ, Wilcox C S: Effects of Ang II type 1 and type 2 receptors on oxidative stress and renal NADPH oxidase and SODs expression. Am J Physiol Regul Integr Comp Physiol 285: R117-R124, 2003
16. Kojda G, Harrison D: Interactions between NO and reactive oxygen species: Pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res 43: 562-571, 1999
17. Adachi T, Matsui R, Xu S, Kirber M, Lazar HL, Sharov VS, Schoneich C, Cohen RA: Antioxidant improves smooth muscle sarco/endoplasmic reticulum Ca(2+)-ATPase function and lowers tyrosine nitration in hypercholesterolemia and improves nitric oxide-induced relaxation. Circ Res 90: 1114-1121, 2002
18. Quinn MT, Curnutte JT, Parkos CA, Mullen ML, Scott PJ, Erickson RW, Jesaitis AJ: Reconstitution of defective respiratory burst activity with partially purified human neutrophil cytochrome B in two genetic forms of chronic granulomatous disease: possible role of Rap1A. Blood 79: 2438-2445, 1992
19. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, Wilcox CS: Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39: 269-274, 2002
20. Winer J, Jung CK, Shackel I, Williams PM: Development and validation of the real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270: 41-49, 1999
21. Wang D, Borrego-Conde L, Falck JR, Sharma KK, Wilcox CS, Umans JG: Contributions of NO, EDHF and EETs to endothelium-dependent relaxation in rabbit renal afferent arterioles. Kidney Int 63: 2187-2193, 2003
22. Ito S, Carretero OA: Impaired response to acetylcholine despite intact endothelium-derived relaxing factor/nitric oxide in isolated perfused afferent arterioles of the spontaneously hypertensive rat. J Cardiovasc Pharmacol 20: S187-S189, 1992
23. - or as SOD mimics? J Biol Chem 271: 26026-26031, 1996
24. 2 receptor protein in rats with angiotensin-dependent hypertension. Hypertension 33: 96-101, 2001
25. De León H, Garcia R: Angiotensin II receptor subtypes in rat renal preglomerular vessels. Receptor 2: 253-260, 1992
26. Griendling KK, Sorescu D, Ushio-Fukai M: NAD(P)H oxidase: Role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000
27. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K, Munzel T: Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90: E58-E65, 2002
28. Juncos LA, Ito S, Carretero OA, Garvin JL: Removal of endothelium-dependent relaxation by antibody and complement in afferent arterioles. Hypertension 1[Suppl]: 154-159, 1994
29. Tojo A, Kimoto M, Wilcox CS: Renal expression of constitutive NOS and DDAH: Separate effects of salt intake and angiotensin. Kidney Int 58: 2075-2083, 2000
30. Wattanapitayakul SK, Weinstein DM, Holycross BJ, Bauer JA: Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders. FASEB J 14: 271-278, 2000
31. Zou MH, Shi C, Cohen RA: Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 109: 817-826, 2002
32. Skov K, Mulvany MJ: Remodeling of the renal resistance vessels in hypertension. Adv Org Biol 9: 331-346, 2000
33. Norrelund H, Christensen KL, Samani NJ, Kimber P, Mulvany MJ, Korsgaard N: Early narrowed afferent arteriole is a contributor to the development of hypertension. Hypertension 24: 301-308, 1994
34. Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriquez-Iturbe B: Mechanisms of disease: Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med 346: 913-923, 2002